Massive Bio Lands $9 Million for Its AI-Powered Oncology Clinical Trial Platform - Grit Daily News

Cancer is a rampant disease that kills many every year, and to combat it, new and improved treatments are a must. Enter Massive Bio, which believes clinical trials might hold the key to those treatments. Through its platform, the company leverages various services and smart data to ensure engagement in cancer clinical trials, both from the patients and the providers. Now, with additional funding, Massive Bio can grow and expand even further. To learn more about the company and its future, check out the following article.